WNBA Star Napheesa Collier Joins Team Opill® for Candid Conversations on Women's Health
Opill®, the first and only daily birth control pill available without a prescription in the U.S., announces a partnership with WNBA Star and Olympic Gold Medalist Napheesa Collier. This collaboration extends Opill's multi-year partnership with the WNBA. Collier, a mother and advocate for women's health, will participate in educational events on college campuses to raise awareness about Opill® and reproductive health options.
Developed by Perrigo, Opill® represents a significant advancement in women's healthcare, offering convenient and accessible contraception without the need for a healthcare provider visit. The partnership aims to empower women to take charge of their reproductive health and increase access to birth control.
Opill®, il primo e unico contraccettivo orale disponibile senza prescrizione negli Stati Uniti, annuncia una collaborazione con la stella della WNBA e medaglia d'oro olimpica Napheesa Collier. Questa collaborazione estende il partnership di Opill con la WNBA per diversi anni. Collier, madre e sostenitrice della salute delle donne, parteciperà a eventi educativi nei campus universitari per sensibilizzare sull'Opill® e sulle opzioni di salute riproduttiva.
Sviluppato da Perrigo, Opill® rappresenta un avanzamento significativo nella salute delle donne, offrendo contracezione conveniente e accessibile senza la necessità di una visita dal fornitore di assistenza sanitaria. La partnership mira a responsabilizzare le donne nel prendere in mano la propria salute riproduttiva e ad aumentare l'accesso alla contraccezione.
Opill®, la primera y única pastilla anticonceptiva diaria disponible sin receta en EE. UU., anuncia una colaboración con la estrella de la WNBA y medallista de oro olímpica Napheesa Collier. Esta colaboración amplía el acuerdo multianual de Opill con la WNBA. Collier, madre y defensora de la salud de las mujeres, participará en eventos educativos en los campus universitarios para concienciar sobre Opill® y las opciones de salud reproductiva.
Desarrollado por Perrigo, Opill® representa un avance significativo en la atención médica de las mujeres, ofreciendo un anticonceptivo conveniente y accesible sin necesidad de visitar a un proveedor de atención médica. La asociación tiene como objetivo empoderar a las mujeres para que tomen control de su salud reproductiva y aumentar el acceso a la anticoncepción.
Opill®, 미국에서 처방전 없이 구입할 수 있는 첫 번째이자 유일한 일일 피임약으로, WNBA 스타이자 올림픽 금메달리스트인 Napheesa Collier와 파트너십을 발표합니다. 이 협업은 Opill과 WNBA 간의 다년간 파트너십을 확장합니다. Collier는 어머니이자 여성 건강 지지자로서, 대학 캠퍼스에서 Opill®과 생식 건강 옵션에 대한 인식을 높이기 위한 교육 행사에 참여할 것입니다.
Perrigo에 의해 개발된 Opill®은 여성 건강 관리의 중요한 발전을 나타내며, 의료 서비스 제공자 방문 없이 편리하고 접근 가능한 피임 수단을 제공합니다. 이 파트너십은 여성들이 자신의 생식 건강을 관리할 수 있도록 권한을 부여하고 피임 접근성을 증가시키는 것을 목표로 합니다.
Opill®, la première et seule pilule contraceptive quotidienne disponible sans ordonnance aux États-Unis, annonce un partenariat avec la star de la WNBA et médaillée d'or olympique Napheesa Collier. Cette collaboration prolonge le partenariat pluriannuel d'Opill avec la WNBA. Collier, mère et défenseure de la santé des femmes, participera à des événements éducatifs sur les campus universitaires pour sensibiliser sur Opill® et les options de santé reproductive.
Développé par Perrigo, Opill® représente une avancée significative dans le domaine de la santé des femmes, offrant une contraception pratique et accessible sans avoir besoin de consulter un professionnel de santé. Ce partenariat vise à responsabiliser les femmes dans la gestion de leur santé reproductive et à accroître l'accès à la contraception.
Opill®, die erste und einzige tägliche Antibabypille, die in den USA ohne Rezept erhältlich ist, kündigt eine Partnerschaft mit WNBA-Star und Olympiagoldmedaillengewinnerin Napheesa Collier an. Diese Zusammenarbeit erweitert Opills mehrjährige Partnerschaft mit der WNBA. Collier, eine Mutter und Befürworterin der Frauengesundheit, wird an Bildungs-Events auf Universitäts-Campus teilnehmen, um das Bewusstsein für Opill® und Reproduktionsgesundheitsoptionen zu schärfen.
Entwickelt von Perrigo, stellt Opill® einen bedeutenden Fortschritt in der Gesundheitsversorgung von Frauen dar und bietet bequemen und zugänglichen Schutz ohne den Besuch eines Gesundheitsdienstleisters. Die Partnerschaft zielt darauf ab, Frauen zu ermächtigen, die Kontrolle über ihre reproduktive Gesundheit zu übernehmen und den Zugang zur Verhütung zu erhöhen.
- Partnership with high-profile WNBA star Napheesa Collier may increase brand visibility and reach
- Educational events on college campuses could drive awareness and potential sales of Opill®
- Opill® is the first OTC daily birth control pill in the U.S., potentially capturing a significant market share
- None.
- Opill® and Collier will hit the road to talk to women about their reproductive health options.
GRAND RAPIDS, Mich., Oct. 15, 2024 /PRNewswire/ -- Today, Opill®—the first and only daily birth control pill available without a prescription in the U.S.—announces the launch of its partnership with WNBA Star and two-time Olympic Gold Medalist Napheesa Collier. The collaboration builds on Opill's multi-year partnership with the Women's National Basketball Association (WNBA).
"One of the reasons Opill partnered with the WNBA is because the players are so passionate about using their platform to champion causes they believe in," said Leila Bahbah, Perrigo
Collier - an Olympic Gold Medalist, starting forward for the Minnesota Lynx, and a mother - is an advocate for women, and says that she's ready for the conversations, even if they're difficult.
"It is important, especially now, to talk to women about their options when it comes to reproductive health," said Collier. "I am ready to get out there and have these very important conversations, and to help women learn about accessing the birth control that's right for them, including Opill."
Collier was most recently named the Kia 2024 WNBA Defensive Player of the Year and finished second in MVP voting. Her resume also includes the 2019 Kia WNBA Rookie of the Year award, and four AT&T WNBA All-Star selections in addition to those two Olympic gold medals as part of Team
"I don't take for granted the opportunity to be part of positive change now that will continue to impact the next generation. I am proud to play a part in helping women get access to birth control if they want it."
As part of the partnership, Collier will hit the road with Opill® in support of the brand's efforts to reach students on college campuses nationwide. These educational events will aim to increase awareness about the availability of Opill® and educate students on reproductive health and the importance of safe, effective and affordable contraception in the
Opill®, developed by Perrigo, is the first daily birth control pill available without a prescription in the
To learn more about Opill®, visit Opill.com or follow @opill_OTC on Instagram, TikTok, Facebook, Threads and X.
About Opill®
Opill® is the first ever and only over-the-counter birth control pill available in
About Perrigo
Perrigo Company plc (NYSE: PRGO), is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com.
Contact
Media:
All Opill®-related media inquiries to be directed to: press@opill.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/wnba-star-napheesa-collier-joins-team-opill-for-candid-conversations-on-womens-health-302275871.html
SOURCE Perrigo Company plc
FAQ
What is Opill® and how is it different from other birth control pills?
Who is partnering with Opill® for women's health conversations?
What activities will Napheesa Collier be involved in as part of the Opill® partnership?
How can investors learn more about Perrigo's (PRGO) Opill® product?
